Predictive Parameters for Therapeutic Efficacy of Initial Combination Therapy With Sitagliptin and Metformin in Type 2 Diabetic Patients.
Phase of Trial: Phase IV
Latest Information Update: 05 Jan 2012
At a glance
- Drugs Metformin (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms COSMETIC
- 07 Jun 2017 Biomarkers information updated
- 05 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2011 Planned end date changed from May 2011 to Jul 2011 as reported by ClinicalTrials.gov.